4//SEC Filing
McIver Zachariah 4
Accession 0001415889-25-000677
CIK 0001817713other
Filed
Jan 2, 7:00 PM ET
Accepted
Jan 3, 8:10 PM ET
Size
7.3 KB
Accession
0001415889-25-000677
Insider Transaction Report
Form 4
McIver Zachariah
Chief Medical Officer
Transactions
- Award
Common Stock
2025-01-02+26,000→ 26,000 total - Award
Stock option (right to buy)
2025-01-02+91,000→ 91,000 totalExercise: $53.24Exp: 2035-01-01→ Common Stock (91,000 underlying)
Footnotes (2)
- [F1]Represents the grant of restricted stock units ("RSUs"), each of which represents a contingent right to receive one share of the Issuer's common stock. The RSUs vest in four equal annual installments beginning on January 1, 2026.
- [F2]25% of the shares subject to the option vest on January 1, 2026 and the balance will vest in equal monthly installments thereafter over a three year period.
Documents
Issuer
Janux Therapeutics, Inc.
CIK 0001817713
Entity typeother
Related Parties
1- filerCIK 0002050056
Filing Metadata
- Form type
- 4
- Filed
- Jan 2, 7:00 PM ET
- Accepted
- Jan 3, 8:10 PM ET
- Size
- 7.3 KB